15 related articles for article (PubMed ID: 38563483)
1. TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA.
Han H; Zhou H; Li J; Feng X; Zou D; Zhou W
Cell Death Discov; 2017; 3():17052. PubMed ID: 29018571
[TBL] [Abstract][Full Text] [Related]
2. 6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5.
Wang LL; Li RT; Zang ZH; Song YX; Zhang YZ; Zhang TF; Wang FZ; Hao GP; Cao L
Med Oncol; 2023 Aug; 40(9):266. PubMed ID: 37566135
[TBL] [Abstract][Full Text] [Related]
3. CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells.
Li ZJ; Hou YJ; Hao GP; Pan XX; Fei HR; Wang FZ
J Cell Commun Signal; 2020 Dec; 14(4):377-387. PubMed ID: 32200503
[TBL] [Abstract][Full Text] [Related]
4. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells.
Zhang YY; Feng PP; Wang HF; Zhang H; Liang T; Hao XS; Wang FZ; Fei HR
Chem Biol Interact; 2022 Sep; 365():110076. PubMed ID: 35948134
[TBL] [Abstract][Full Text] [Related]
5. Caudatin potentiates the anti-tumor effects of TRAIL against human breast cancer by upregulating DR5.
Fei HR; Yuan C; Wang GL; Zhao Y; Li ZJ; Du X; Wang FZ
Phytomedicine; 2019 Sep; 62():152950. PubMed ID: 31102888
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
[TBL] [Abstract][Full Text] [Related]
7. Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5.
Liu X; Wang LL; Duan CY; Rong YR; Liang YQ; Zhu QX; Hao GP; Wang FZ
Cell Biol Int; 2024 Apr; ():. PubMed ID: 38563483
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
